PubRank

Nadia Di Muzio

Author PubWeight™ 53.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis. Eur Urol 2012 3.53
2 Indications for pelvic nodal treatment in prostate cancer should change. Validation of the Roach formula in a large extended nodal dissection series. Int J Radiat Oncol Biol Phys 2011 2.55
3 Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. Eur Urol 2012 2.46
4 Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis. Eur Urol 2011 2.29
5 Hypofractionated image-guided IMRT in advanced pancreatic cancer with simultaneous integrated boost to infiltrated vessels concomitant with capecitabine: a phase I study. Int J Radiat Oncol Biol Phys 2013 2.04
6 Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy. Eur J Nucl Med Mol Imaging 2009 1.66
7 [11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging. J Urol 2010 1.56
8 Reirradiation: hopes and concerns of the radiation oncologist. Tumori 2011 1.41
9 IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy. Radiother Oncol 2009 1.27
10 Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation. Int J Radiat Oncol Biol Phys 2008 1.21
11 Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy. Radiother Oncol 2006 1.18
12 Inflammatory pseudotumor of mediastinum treated with tomotherapy and monitored with FDG-PET/CT: case report and literature review. Tumori 2010 1.13
13 Detection and compensation of organ/lesion motion using 4D-PET/CT respiratory gated acquisition techniques. Radiother Oncol 2010 1.01
14 Evidence of limited motion of the prostate by carefully emptying the rectum as assessed by daily MVCT image guidance with helical tomotherapy. Int J Radiat Oncol Biol Phys 2008 0.96
15 Helical tomotherapy and intensity modulated proton therapy in the treatment of early stage prostate cancer: a treatment planning comparison. Radiother Oncol 2010 0.93
16 A two-variable linear model of parotid shrinkage during IMRT for head and neck cancer. Radiother Oncol 2010 0.92
17 Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single-institute analysis of 742 patients. Int J Radiat Oncol Biol Phys 2010 0.91
18 Contrast enhanced 4D-CT imaging for target volume definition in pancreatic ductal adenocarcinoma. Radiother Oncol 2008 0.90
19 Dose-volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer. Int J Radiat Oncol Biol Phys 2009 0.89
20 Changes in glucose metabolism during and after radiotherapy in non-small cell lung cancer. Tumori 2009 0.88
21 Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis. Int J Radiat Oncol Biol Phys 2010 0.86
22 Motion management in positron emission tomography/computed tomography for radiation treatment planning. Semin Nucl Med 2012 0.86
23 Remission of refractory neurosarcoidosis treated with brain radiotherapy: a case report and a literature review. Neurologist 2008 0.86
24 Modeling set-up error by daily MVCT for prostate adjuvant treatment delivered in 20 fractions: Implications for the assessment of the optimal correction strategies. Radiother Oncol 2009 0.85
25 Simultaneous integrated boost (SIB) for nasopharynx cancer with helical tomotherapy. A planning study. Strahlenther Onkol 2007 0.85
26 Internal target volume defined by contrast-enhanced 4D-CT scan in unresectable pancreatic tumour: evaluation and reproducibility. Radiother Oncol 2010 0.84
27 Feasibility of an adaptive strategy in preoperative radiochemotherapy for rectal cancer with image-guided tomotherapy: boosting the dose to the shrinking tumor. Int J Radiat Oncol Biol Phys 2013 0.84
28 Sparing the penile bulb in the radical irradiation of clinically localised prostate carcinoma: A comparison between MRI and CT prostatic apex definition in 3DCRT, Linac-IMRT and Helical Tomotherapy. Radiother Oncol 2009 0.84
29 Adenoid cystic carcinoma of trachea treated with adjuvant hypofractionated tomotherapy. Case report and literature review. Tumori 2008 0.83
30 Introducing the Jacobian-volume-histogram of deforming organs: application to parotid shrinkage evaluation. Phys Med Biol 2011 0.83
31 Hypofractionated adjuvant radiotherapy with helical tomotherapy after radical prostatectomy: planning data and toxicity results of a Phase I-II study. Radiother Oncol 2008 0.83
32 High-dose adjuvant radiotherapy after radical prostatectomy with or without androgen deprivation therapy. Int J Radiat Oncol Biol Phys 2011 0.82
33 Postoperative radiotherapy in prostate cancer: acquired certainties and still open issues. A review of recent literature. Tumori 2011 0.82
34 Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients. Int J Radiat Oncol Biol Phys 2009 0.82
35 Image-guided radiation therapy: a new era for the radiation oncologist? Int J Clin Oncol 2009 0.82
36 Semiautomatic technique for defining the internal gross tumor volume of lung tumors close to liver/spleen cupola by 4D-CT. Med Phys 2010 0.81
37 Density variation of parotid glands during IMRT for head-neck cancer: correlation with treatment and anatomical parameters. Radiother Oncol 2012 0.81
38 Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer. Radiother Oncol 2007 0.81
39 Application of failure mode and effects analysis (FMEA) to pretreatment phases in tomotherapy. J Appl Clin Med Phys 2013 0.81
40 Helical tomotherapy for scalp recurrence of primary eccrine mucinous adenocarcinoma. Tumori 2010 0.81
41 Contemporary role of radiation therapy in the adjuvant or salvage setting following radical prostatectomy. Curr Opin Urol 2011 0.81
42 Salvage brachytherapy for local recurrence after radical prostatectomy and subsequent external beam radiotherapy. Urology 2003 0.80
43 [11C]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months. Tumori 2010 0.80
44 Predictors of acute bowel toxicity in patients treated with IMRT whole pelvis irradiation after prostatectomy. Radiother Oncol 2010 0.80
45 Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial. Ann Surg Oncol 2012 0.79
46 Role of PET/CT in the clinical management of locally advanced pancreatic cancer. Tumori 2012 0.79
47 Physics aspects of prostate tomotherapy: planning optimization and image-guidance issues. Acta Oncol 2008 0.79
48 Helical tomotherapy and intensity modulated proton therapy in the treatment of dominant intraprostatic lesion: a treament planning comparison. Radiother Oncol 2013 0.77
49 Ionizing radiations increase the activity of the cell surface glycohydrolases and the plasma membrane ceramide content. Glycoconj J 2012 0.77
50 Radiobiology and molecular oncology: how are they changing radiotherapy in clinical practice? Tumori 2010 0.77
51 18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy. Clin Nucl Med 2017 0.75
52 In-gantry or remote patient positioning? Monte Carlo simulations for proton therapy centers of different sizes. Radiother Oncol 2011 0.75
53 Radiotherapy for head and neck cancer in Lombardy: a survey by the Lombardy Group of the Italian Association for Radiation Oncology. Tumori 2015 0.75
54 Consolidation radiotherapy for a rare case of extranodal mucosa-associated lymphoid tissue non-Hodgkin's lymphoma synchronous with prostate adenocarcinoma. Tumori 2010 0.75
55 Analysis of serial CT images for studying the RT effects in head-neck cancer patients. Conf Proc IEEE Eng Med Biol Soc 2015 0.75